Connect with us

Insight

How Agentic AI and nursing models of care are combatting decision fatigue in women’s health

Published

on

Women are no strangers to decision fatigue.

From navigating reproductive health to managing chronic conditions and making daily lifestyle choices, the sheer volume of decisions women face can be overwhelming.

Add to this the complexity of healthcare options, time constraints, and information overload, and it’s no surprise that decision fatigue—a state of mental exhaustion that impairs sound decision-making—is a growing concern in women’s health.

But what if there was a way to reduce this cognitive burden while empowering women to make informed, confident choices?

Enter Ema, the first Agentic AI designed to blend the holistic principles of nursing care with cutting-edge technology, offering scalable, empathetic support tailored to women’s unique needs.

Decision Fatigue in Women’s Health: A Growing Challenge

Decision fatigue is more than a buzzword; it’s a real psychological phenomenon that disproportionately impacts women, especially in healthcare.

Studies show that:

  • Women often face information overload, with conflicting advice from online sources adding to the confusion.
  • Limited time during provider consultations creates pressure to make quick decisions, often without fully understanding the options.
  • Emotional factors, such as anxiety and stress, further impair decision-making capabilities.

For example, a woman navigating fertility treatments may need to weigh multiple complex factors—from medical protocols to emotional and financial implications.

Similarly, those managing chronic conditions like endometriosis or diabetes must make daily decisions that affect their long-term health outcomes.

The result?

A sense of overwhelm that leads to suboptimal choices or delays in critical healthcare decisions.

The Nursing Model of Care: A Proven Framework

The nursing model of care offers a solution to decision fatigue by prioritizing holistic, patient-centred care:

  • Simplification: Nurses distill complex medical information into clear, actionable steps.
  • Emotional Support: Nurses help patients feel confident in their choices by building trust and providing reassurance.
  • Shared Decision-Making: This collaborative approach ensures patients’ values and preferences are respected while guiding them toward informed decisions.

These principles alleviate the mental burden of decision-making and enhance patient autonomy and satisfaction.

Ema: Bringing the Nursing Model to Life with AI

Ema takes the best of the nursing model of care and amplifies it with the power of Agentic AI. Designed to act as a personalised health companion.

How Ema Tackles Decision Fatigue: Real-Life Scenarios

  • Managing Fertility Treatments:
    For a woman overwhelmed by the options for fertility treatments, Ema simplifies the journey by presenting her with clear, tailored recommendations and automating reminders for the next steps.
  • Navigating Chronic Disease:
    A woman managing diabetes might struggle with daily decisions about medication, diet, and exercise. Ema reduces this burden by sending personalised prompts, tracking progress, and providing encouragement.
  • Understanding Abnormal Test Results:
    When test results return abnormal, Ema provides clear, non-alarming explanations and actionable suggestions, reducing stress and confusion.
  • Choosing the Right Breast Pump:
    For new mothers overwhelmed by breastfeeding and pumping, Ema simplifies pumping data by asking personalised questions about lifestyle, milk production needs, and work conditions. Based on the user’s responses, Ema recommends tips and links to resources, lactation consultants, or support groups for new moms.

Why Agentic AI Matters in Women’s Health

Agentic AI is about more than automation—it’s about empowerment.

Agentic AI doesn’t just provide answers; it actively engages users, fostering confidence and autonomy in their healthcare decisions.

By integrating the principles of nursing care with intelligent automation, Agentic AI can deliver:

  • Enhanced Health Literacy: Users better understand their health, enabling informed decisions.
  • Reduced Cognitive Load: With AI managing the background tasks, women can focus on what truly matters.
  • Stronger Engagement: Personalised, empathetic interactions build trust and long-term relationships.

The Future of Decision Support in Women’s Health

As healthcare grows increasingly complex, tools like Ema represent a critical shift toward patient-centred innovation.

By blending the art of nursing care with the science of AI, Ema is more than a tool—it’s a trusted partner in empowering women to navigate their health with confidence and ease.

For women facing decision fatigue, this isn’t just a solution; it’s a revolution.

Learn more about Ema at emaapp.com

Continue Reading
1 Comment

1 Comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Insight

Topical HRT protects bone density in women with period loss – study

Published

on

Transdermal HRT best protects bone density in women with functional hypothalamic amenorrhoea, a condition that stops periods, a review of trials has found.

The meta-analysis pooled randomised clinical trials involving 692 participants and found transdermal hormone replacement therapy and teriparatide increased bone mineral density by between 2 and 13 per cent.

Functional hypothalamic amenorrhoea can follow anorexia or intense exercise. Bone mineral density measures bone strength and the amount of mineral in bone.

Around half of women with the condition have low bone mineral density, compared with about 1 per cent of healthy women, and their fracture risk is up to seven times higher.

The research was conducted by scientists at Imperial College London and Imperial College Healthcare NHS Trust.

Professor Alexander Comninos, senior author of the study and consultant endocrinologist at the trust, said: “Bone density is lost very rapidly in FHA and so addressing bone health early is very important to reduce the lifelong risk of fractures.

“Our study provides much needed comparisons of all the available treatments from all available studies.

“Clearly the best treatment is to restore normal menstrual cycles and therefore oestrogen levels through various psychological, nutritional or exercise interventions – but that is not always possible.

“The foundation for bone health is good calcium and vitamin D intake (through diet and/or supplements) but we have additional treatments that are more effective.”

When FHA is diagnosed, clinicians first try to restore periods through lifestyle measures, including psychological and dietary support, but these can fail. Guidelines then recommend giving oestrogen, though the best form was unclear.

The team reviewed all prior randomised trials comparing therapies, including oral and transdermal oestrogen, and also assessed teriparatide, a prescription bone-building drug used for severe osteoporosis.

They found no significant benefit for oral contraceptive pills or oral hormone therapy.

A recent UK audit reported that about a quarter of women with anorexia-related FHA are prescribed the oral contraceptive pill for bone loss; the study suggests using transdermal therapy instead.

Comninos said: “Our goal is simple: to help women receive the right treatment sooner and to protect their bone health in the long-term.

“We hope this study provides clinicians with better evidence to choose transdermal oestrogen when prescribing oestrogen and so inform future practice guidelines.

“Right now, millions of women with FHA may not be receiving the best treatments for their bone health.”

Continue Reading

Insight

AI cuts interval breast cancers in Swedish trial

Published

on

An AI tool cut interval breast cancers by 12 per cent in a Swedish screening trial of more than 105,000 women.

The study also found 27 per cent fewer aggressive breast cancers detected at screening when AI was used.

Interval cancers are cancers found between routine screening appointments because they were missed at the original scan. They are often more dangerous and linked to higher death rates than cancers found at screening.

The MASAI trial is described as the first large randomised study to test whether AI can improve mammography screening, which uses low-dose X-rays to examine breast tissue for signs of cancer.

The AI tool, called Transpara Detection and developed by ScreenPoint Medical, supported radiologists in analysing mammography images.

Earlier results from the same trial showed that Transpara Detection increased cancers found by 29 per cent and reduced radiologist workload by 44 per cent compared with standard double-reading, where two radiologists independently review each scan.

The latest findings indicate higher accuracy with AI support. Sensitivity, the ability to detect cancer, was 6.7 percentage points higher in the AI group while specificity, the ability to rule out healthy cases, was maintained. Results were similar across age groups and breast density levels.

Women screened with AI had 16 per cent fewer invasive interval cancers and 21 per cent fewer large interval cancers than those in the standard screening group.

The system also helps doctors assess risk more precisely by subdividing suspicious findings into BI-RADS 4 categories A, B and C. BI-RADS (Breast Imaging Reporting and Data System) is a standardised scale that guides whether a patient needs closer monitoring, further tests or treatment.

Continue Reading

Insight

WUKA and Royal Yachting Association partner to support women and girls in sailing

Published

on

WUKA has announced a groundbreaking partnership with the Royal Yachting Association (RYA), including RYA Scotland and RYA Northern Ireland, supporting women and girls in sailing.

Building on WUKA’s growing #TackleAnything campaign – which has already reached thousands of girls across sports in the UK – this collaboration brings practical period solutions into sailing.

Together, WUKA and the RYA are committed to breaking down barriers so periods never limit confidence, participation, or performance on the water.

Ruby Raut, WUKA founder & CEO, said: “Partnering with the RYA has been incredibly important for us at WUKA.

“Sailing is an amazing way for women and girls to build confidence, and periods shouldn’t hold anyone back from enjoying the water or reaching their full potential.

“Through this partnership and our #TackleAnything campaign, we’re proud to provide practical solutions and innovative products that help female sailors feel comfortable, confident, and free to focus on learning, performing, and having fun.

“Breaking down barriers and supporting women to tackle anything — on land, at sea, and everywhere in between – has never felt more meaningful.”

WUKA, which stands for Wake-Up Kick Ass, shares the RYA’s commitment to inclusivity and empowerment.

In 2023, WUKA launched #TackleAnything, a campaign supporting women, girls and sportspeople with periods. Since its launch, the initiative has reached 3,576 girls across 46 clubs and partnered with a range of sports across the UK – from Scottish Gymnastics to Titans wheelchair basketball – helping young athletes play without limits and stay confident, comfortable, and in the game.

The brand offers period-friendly aquatic apparel and practical solutions that help women train and compete with freedom of movement and total assurance.

Through this partnership, WUKA will provide innovative period swimwear for young sailors across key RYA programmes, including the NI Sailing Team, the RYA Scotland Performance Pathway Programme, and the British Sailing Pathways Talent Academies.

By combining WUKA’s mission to challenge stigma with the RYA’s commitment to inclusion, the partnership ensures young sailors can focus on what matters most – learning, performing, and enjoying their time on the water – with confidence and comfort. RYA members will also receive a 10 per cent discount on WUKA products.

Sailing offers incredible benefits for women and girls, but time on the water can present unique challenges -particularly during menstruation.

Together, WUKA and the RYA are providing practical solutions that remove these barriers, helping young sailors participate fully and confidently in the sport.

Sara Sutcliffe, RYA CEO, said: “At the RYA, we have been making strides to break down barriers for women of all ages to help ensure they can experience the water in a supportive and positive environment.

“From education workshops and practical sessions, we want to make sure our female sailors are empowered and this partnership is another great example of how we can demonstrate possible tools to equip them to succeed”.

This partnership is part of the RYA’s wider commitment to making sailing a sport where women and girls can thrive. Alongside initiatives such as the Female Futures Group, the Women’s Race Officials Programme and all new Talent Academy Female Future’s Camps; it demonstrates a continued focus on removing barriers and creating meaningful opportunities across every stage of the sailing.

WUKA’s involvement ensures that practical solutions are available on the water, from innovative period swimwear to support resources, helping young sailors feel fully equipped and confident during training and competition.

By integrating these tools into RYA programmes, WUKA brings a new level of comfort and assurance to female athletes, allowing them to focus entirely on performance, enjoyment, and growth in the sport.

For any women and girls looking to learn more about sailing, visit www.rya.org.uk.

For more information on WUKA visit www.wuka.co.uk.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.